fbpx
Medical Innovation Exchange

Bristol Myers triples-down on Immatics, bringing deal to $4.2B total biobucks. Why not just buy it?

https://www.fiercebiotech.com/biotech/bristol-myers-triples-down-immatics-bringing-deal-42b-total-biobucks-why-not-just-buy-it

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.